01011.HK
China NT Pharma Group Company Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 0.42
−1.19%Margins
Gross margin
28.5%
EBITDA margin
-37.9%
EBIT margin
-47.6%
Net margin
-181.4%
FCF margin
-45.6%
88.3%
Return on equity
-15.3%
Return on assets
-11.5%
Return on invested capital
0.11x
Asset turnover
-HKD 28.6M
Cash from operations
HKD 0.02
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026